One of China’s premium Shanghainese dining chains abruptly shut 10 outlets in the city, becoming the latest casualty of the country’s consumption slump and sparking an outcry from diners just days before the Lunar New Year holidays. Image: Damon Lam / Unsplash Source: Bloomberg
President Donald Trump posted a racist video to his Truth Social account late Thursday with an AI-generated video of the Obamas as apes. The 62-second video, shared at 11:44 p.m. ET by the U.S. president, mostly runs through a conspiracy theory about the 2026 election alleging that voting machines in certain battleground states were rigged…
Nvidia’s Jensen Huang criticized OpenAI’s business strategy as the chip giant plans to invest up to $100 billion into the AI startup, per reports. Image: BoliviaInteligente / Unsplash Source: CNBC
Intel Shares Fall on Report Nvidia Halts Production Test The semiconductor industry’s delicate dance of collaboration and competition hit a sour note this week. Intel Corp. shares fell in premarket trading Wednesday following a report that Nvidia Corp. has halted a test to use Intel’s production process for its next-generation chips. This development strikes at…
French, UK Shares Trade Steady in Thin Christmas Eve Trading European markets entered a state of suspended animation on Christmas Eve. While most major continental exchanges were shuttered for the holiday, the UK’s FTSE 100 and France’s CAC 40 saw minimal activity. Trading volumes were predictably anemic, resulting in flat to marginally positive closes for…
Oracle Corporation is facing a profound moment of reckoning, its stock on track for its worst quarterly performance in over two decades. This precipitous decline comes as the company’s new dual-CEO structure, led by Clay Magouyrk and Mike Sicilia, confronts a singular, multibillion-dollar question from Wall Street. Can the legacy software giant successfully finance and…
Ascletis Pharma Shares Surge on Drug Results Ascletis Pharma Inc. shares surged Tuesday, posting their biggest rally since April, after mid-stage results for its oral weight-loss drug suggested a potential best-in-class profile. Key Details The positive movement followed the release of promising mid-stage trial results for the company’s oral weight-loss treatment. Image: Road Trip with…
